This test is most useful if any of these apply to you.
Seeing a streptococcus reported in your urine can be unsettling, but the finding is more of a question than an answer. The same organism can sit quietly on the genitourinary lining of a perfectly healthy person or, in the right circumstances, drive a real infection.
What this result tells you depends almost entirely on context: whether you have symptoms, how much grew, and whether the specimen was cleanly collected. This entry explains what the bacterium is, when its presence matters, and what to do with an unexpected report.
Streptococcus anginosus is a living microorganism. It is one of three closely related bacteria that together form the Streptococcus anginosus group (SAG), alongside S. constellatus and S. intermedius. In the lab it appears as a gram-positive coccus (a round, purple-staining bacterium that grows without needing much oxygen).
Because it is an organism rather than a substance your cells produce, there is no meaningful "high" or "low" level the way there is for cholesterol or blood sugar. The clinically useful distinction is presence versus absence, and, when present, whether it is causing trouble or simply living there. This bacterium is a normal resident of the mouth, throat, gut, and genitourinary tract, which is exactly why a urine finding is not automatically a diagnosis.
The central interpretive challenge is that this organism is often just passing through. Studies of the urogenital microbiome in healthy, symptom-free women detect Streptococcus anginosus without any sign of disease. So a positive urine report, on its own, does not establish that you have a urinary tract infection (a UTI).
This is where the "more must be worse" instinct breaks down. Detecting the bacterium is not inherently a bad result, and not detecting it is not inherently reassuring. Think of it as a context-dependent finding rather than a good-number-versus-bad-number marker: the same organism means different things in a person with burning and urgency than in someone with no symptoms at all. What converts a finding into a diagnosis is the combination of the organism plus urinary symptoms plus signs of inflammation in the urine.
Streptococcus anginosus can genuinely infect the urinary and genital tract, it just is not the most common cause. In one hospital series of adults with invasive Streptococcus anginosus group infections, genitourinary infections made up about 8.5% of cases, well behind skin and soft-tissue infections (55%) and abdominal infections (24%). The exact mix of sites varies from one cohort to another, but across studies urinary involvement is real yet is not the dominant syndrome for this bacterium.
Within the broader group, S. anginosus is the species most often isolated overall, accounting for 54.9% of specimens (254 of 463) in one large cohort. A practical consequence for you: if this organism turns up in your urine while you have symptoms, it deserves to be taken seriously as a possible cause, but the workup should still confirm it is the culprit rather than a bystander.
One trait sets this bacterium apart from ordinary urinary bugs: a strong tendency to wall off into pockets of pus. In one hospital series, abscesses accounted for 68% of cases, and infections were frequently polymicrobial (mixed with other bacteria) in 46% of cases, often alongside gut-type organisms. Other series report different proportions, but the abscess-forming tendency is a consistent feature of this group.
This matters for interpretation. A urine isolate could occasionally be a clue to a deeper process in the abdomen or pelvis rather than a simple bladder infection. Serious invasive infections tend to cluster in people with underlying conditions such as diabetes (38% in one adult cohort, with other series reporting roughly 25 to 31%) and cancer (15% in that cohort), so those groups warrant extra attention when this organism appears.
Carriage of this bacterium in the genital tract is well documented in pregnancy. In a study of pregnant women, anovaginal sampling found Streptococcus anginosus in 4.3% of women (17 of 399). Its presence was linked to a prior history of urinary tract infections and sexually transmitted infections, and to antibiotic use during pregnancy.
Abundance can also shift with normal life events rather than infection. A study following women from pregnancy into the postpartum period found significantly higher proportions of this organism after delivery, tracking a change in the body's internal environment. These associations point to genuine genitourinary relevance without proving the bacterium causes the conditions it accompanies.
You may see headlines linking this bacterium to stomach cancer or stroke. Those findings come from stool and gut microbiome studies, a different sample than urine, and should not be read as applying to a urinary result. In one study, stool levels of the organism were enriched in people with gastric cancer, and in a stroke cohort, gut carriage was associated with worse two-year cardiovascular outcomes.
These are associations from a different specimen, not evidence that finding the organism in your urine predicts cancer or stroke. They are worth knowing only so you do not overinterpret a urine report through the lens of unrelated gut research.
The single biggest source of confusion is that highly sensitive molecular tests find this and other bacteria almost everywhere. In one study, next-generation sequencing (a DNA-based method that reads many organisms at once) was positive in 95% of symptom-free control subjects, versus only 23% by standard urine culture. A molecular positive is therefore easy to over-read as disease.
For an organism like this, a single snapshot rarely settles the question. If you were treated for a symptomatic infection, a follow-up urine test after finishing antibiotics is the way to confirm the bacterium was actually cleared. Tracking before and after treatment is far more informative than any one result.
These organisms also have a documented tendency to persist and recur; genotyping studies have found the same strain returning weeks to more than a year later, with a median gap of about 36 days between episodes in some patients. If symptoms come back, retesting helps distinguish a true relapse from a new, unrelated finding. A sensible rhythm is to test when symptomatic, retest to confirm clearance after treatment, and otherwise avoid repeat testing in the absence of symptoms.
If this bacterium shows up in your urine, the first fork in the road is symptoms. With no urinary symptoms and no signs of inflammation, the most likely explanation is colonization, and aggressive treatment is usually not warranted outside pregnancy or before a urologic procedure. With symptoms, the finding deserves a real workup.
A useful pattern-based approach: pair the result with a urine culture that reports colony counts and antibiotic susceptibility, plus a urine white-cell measurement to confirm inflammation. If you also have fever, abdominal or pelvic pain, or a poor response to treatment, that combination raises the possibility of a deeper abscess and is a reason to involve a clinician and consider imaging. Pregnant patients are a special case where even symptom-free bacteria in the urine are treated, because doing so lowers the risk of kidney infection and low birth weight. For anything beyond a clearly minor, isolated finding, a licensed clinician or clinical microbiologist should tie the test method, your symptoms, and the culture context together.
Evidence-backed interventions that affect your Streptococcus anginosus level
Streptococcus anginosus is best interpreted alongside these tests.
Streptococcus anginosus is included in these pre-built panels.